Zeru Xiao
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: November 25, 2024
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
Journal: Journal of cancer research and clinical oncology
Published: April 23, 2024
Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: May 13, 2023
Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling.
Journal: Breast cancer research : BCR
Published: September 01, 2022
A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer.
Journal: Cancer gene therapy
Published: May 19, 2022
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: September 02, 2021
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: August 23, 2021
Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness.
Journal: Cancer letters
Published: August 11, 2021
DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis.
Journal: Cellular and molecular gastroenterology and hepatology
Published: July 15, 2021
A fluorescent microsphere-based immunochromatographic strip is effective for quantitative fecal blood testing in colorectal cancer screening.
Journal: American journal of translational research
Published: June 07, 2021
Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro.
Journal: Journal of clinical laboratory analysis
Published: June 05, 2021
Last Updated: 09/26/2026